Genetic Etiology of Abdominal Hernia Susceptibility
Genetic Etiology of Abdominal Hernia Susceptibility
批准号:
10006003
负责人:
Nadav Ahituv
金额:
$59.27万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-15 至 2023-08-31
关键词:
AddressAdultAffectAgingAllelesBiologicalBiological AssayCRISPR/Cas technologyChIP-seqChromatinCollaborationsCongenital exomphalosConnective TissueDevelopmentDiagnosisDiseaseElementsEmergency SituationEnhancersEtiologyFamily StudyFemoral HerniaFirst Degree RelativeFoundationsGene Expression RegulationGenesGeneticGenetic Predisposition to DiseaseGenetic RiskGenetic studyGenomicsHealthHealth Care CostsHerniaHernia of abdominal cavityHumanHuman GeneticsImprisonmentIn VitroIndividualInguinal HerniaIntestinesLeadLinkLinkage DisequilibriumLiteratureMethodsModernizationMusMutationNucleic Acid Regulatory SequencesNucleotidesOperative Surgical ProceduresPatientsPhenotypePredispositionProceduresPublic HealthRecurrenceRegulationRegulator GenesRegulatory ElementRiskRoleSeriesSingle Nucleotide PolymorphismSurgical complicationTestingTransposaseUntranslated RNAVariantVentral HerniaWT1 geneWomanchronic painclinical phenotypeclinical practicecohortcommon treatmentcostexperienceexperimental studygenetic analysisgenetic epidemiologygenetic risk factorgenetic variantgenomic locusimprovedin vivoinnovationinsightmenmortality riskmultidisciplinarynovelprecision medicinerepairedrisk varianttooltrait
中文摘要
腹疝是临床实践中最常诊断的疾病,
全世界每年进行两千万例疝修补手术。许多患者经历了严重的
术后并发症,包括慢性疼痛(6%)和疝复发(10%)。延误治疗
有肠嵌顿的风险,需要紧急疝修补手术,并与
有很大的死亡风险因为疝气的风险必须与
与其治疗相关,显然需要更好地了解疝的病因,
改善治疗选择。
我们进行了第一次大规模的疝气风险遗传研究,并在四个新的基因组中鉴定了非编码变异。
腹股沟疝是最常见的疝类型,
这些基因座中的基因(EFEMP1、WT 1、EBF2和ADAMTS6)在小鼠结缔组织中表达。在这里,
我们将通过鉴定其他腹疝亚型的遗传风险位点来扩展我们的发现,
定位和表征这些基因座内的调控元件,并使用体外和体内
体内分析,这些元件内的核苷酸变异如何导致其调节改变和疝
易感性通过将疝风险基因座中的特定遗传变异与其对基因调控的功能效应联系起来,
我们就可以开始了解导致疝气易感性的生物学机制。
我们的研究将通过确定疝亚型的遗传位点填补文献中的一个重要空白,
提供深入了解导致疝气发展的特定生物学机制。一种改进
对疝气形成机制的了解可以指导现代“精确医学”
这将导致预防性非手术治疗的疝治疗方法。
英文摘要
Abdominal hernias are some of the most frequently diagnosed conditions in clinical practice, with more than
twenty million hernia repair surgeries performed annually around the world. Many patients experience serious
post-surgical complications, including chronic pain (6%) and hernia recurrence (10%). Delaying treatment
carries the risk of bowel incarceration, which requires emergency hernia repair surgery and is associated with
a substantial risk of mortality. Because the risks associated with hernias must be balanced against the risks
associated with their treatment, there is a clear need for a better understanding of hernia etiology and
improved treatment options.
We conducted the first large-scale genetic study of hernia risk and identified noncoding variants at four novel
genetic loci underlying the risk of inguinal hernia—the most common type of hernia—and showed that four
genes in these loci (EFEMP1, WT1, EBF2, and ADAMTS6) are expressed in mouse connective tissue. Here,
we will extend our findings by identifying genetic risk loci underlying additional abdominal hernia subtypes,
locating and characterizing regulatory elements within these loci, and demonstrating, using both in vitro and in
vivo assays, how nucleotide variation within these elements can lead to their altered regulation and hernia
susceptibility. By linking specific genetic variants in hernia risk loci to their functional effect on gene regulation,
we can begin to understand the biological mechanisms that lead to hernia susceptibility.
Our study will fill an important gap in the literature by identifying genetic loci underlying hernia subtypes and
provide insights into the specific biological mechanisms that lead to hernia development. An improved
understanding of the mechanisms through which hernias develop can guide a modern `precision medicine'
approach for hernia treatment that will lead to preventative non-surgical treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharmaceutical Sciences and Pharmacogenomics
-
批准号:10652249
-
项目类别:
-
资助金额:$48.62万
-
财政年份:2022
-
负责人:Nadav Ahituv
-
依托单位:
EDGE CMT: Genomic characterization of mammalian adaptation to frugivory
-
批准号:10439977
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2022
-
负责人:Nadav Ahituv
-
依托单位:
EDGE CMT: Genomic characterization of mammalian adaptation to frugivory
-
批准号:10551234
-
项目类别:
-
资助金额:$47.22万
-
财政年份:2022
-
负责人:Nadav Ahituv
-
依托单位:
Pharmaceutical Sciences and Pharmacogenomics
-
批准号:10269779
-
项目类别:
-
资助金额:$47.61万
-
财政年份:2022
-
负责人:Nadav Ahituv
-
依托单位:
Massively parallel characterization of variants and elements impacting transcriptional regulation in dynamic cellular systems
-
批准号:10471968
-
项目类别:
-
资助金额:$179.83万
-
财政年份:2021
-
负责人:Nadav Ahituv
-
依托单位:
Massively parallel characterization of variants and elements impacting transcriptional regulation in dynamic cellular systems
-
批准号:10295427
-
项目类别:
-
资助金额:$92.28万
-
财政年份:2021
-
负责人:Nadav Ahituv
-
依托单位:
Massively parallel characterization of variants and elements impacting transcriptional regulation in dynamic cellular systems
-
批准号:10676325
-
项目类别:
-
资助金额:$179.83万
-
财政年份:2021
-
负责人:Nadav Ahituv
-
依托单位:
Massively parallel characterization of variants and elements impacting transcriptional regulation in dynamic cellular systems
-
批准号:10831639
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2021
-
负责人:Nadav Ahituv
-
依托单位:
Functional characterization of obesity-associated OXTR enhancers
-
批准号:10852690
-
项目类别:
-
资助金额:$8.36万
-
财政年份:2020
-
负责人:Nadav Ahituv
-
依托单位:
From Obesity GWAS to therapeutic targets
-
批准号:10642716
-
项目类别:
-
资助金额:$70.25万
-
财政年份:2020
-
负责人:Nadav Ahituv
-
依托单位:
From Obesity GWAS to therapeutic targets
-
批准号:10200035
-
项目类别:
-
资助金额:$70.25万
-
财政年份:2020
-
负责人:Nadav Ahituv
-
依托单位:
From Obesity GWAS to therapeutic targets
-
批准号:10434790
-
项目类别:
-
资助金额:$70.25万
-
财政年份:2020
-
负责人:Nadav Ahituv
-
依托单位:
Technologies for simultaneous characterization of regulatory activity and protein binding
-
批准号:9807617
-
项目类别:
-
资助金额:$24.09万
-
财政年份:2019
-
负责人:Nadav Ahituv
-
依托单位:
Massively parallel characterization of psychiatric disease associated regulatory elements in defined cell types
-
批准号:10376812
-
项目类别:
-
资助金额:$66.8万
-
财政年份:2018
-
负责人:Nadav Ahituv
-
依托单位:
Massively parallel characterization of psychiatric disease associated regulatory elements in defined cell types
-
批准号:9901610
-
项目类别:
-
资助金额:$67.27万
-
财政年份:2018
-
负责人:Nadav Ahituv
-
依托单位:
Massively parallel reporter assays and genome editing of ENCODE predicted regulatory elements
-
批准号:10238522
-
项目类别:
-
资助金额:$140.95万
-
财政年份:2017
-
负责人:Nadav Ahituv
-
依托单位:
Non-coding/epigenetic regulation
-
批准号:10646398
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2016
-
负责人:Nadav Ahituv
-
依托单位:
Developmental Mechanisms of Human Idiopathic Scoliosis
-
批准号:10646372
-
项目类别:
-
资助金额:$135.83万
-
财政年份:2016
-
负责人:Nadav Ahituv
-
依托单位:
Massively parallel dissection of psychiatric regulatory networks
-
批准号:9265137
-
项目类别:
-
资助金额:$66.22万
-
财政年份:2016
-
负责人:Nadav Ahituv
-
依托单位:
Non-coding/epigenetic regulation
-
批准号:10458402
-
项目类别:
-
资助金额:$35.7万
-
财政年份:2016
-
负责人:Nadav Ahituv
-
依托单位:
海外基金